title: Different kinetics of WT1 and PML-RARalpha gene expression levels during remission induction therapy with all-trans retinoic acid alone in acute promyelocytic leukemia.
authors.forename: Hiroya
authors.initials: H
authors.lastname: Tamaki
authors.forename: Tamotsu
authors.initials: T
authors.lastname: Yamagami
authors.forename: Manabu
authors.initials: M
authors.lastname: Kawakami
authors.forename: Eui Ho
authors.initials: EH
authors.lastname: Kim
authors.forename: Machiko
authors.initials: M
authors.lastname: Mishima
authors.forename: Ichiro
authors.initials: I
authors.lastname: Kawase
authors.forename: Toshihiro
authors.initials: T
authors.lastname: Soma
authors.forename: Hiroyasu
authors.initials: H
authors.lastname: Ogawa
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D015973:Gene Expression Regulation, Leukemic / Q000187:drug effects; D018922:HL-60 Cells; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D015514:Oncogene Proteins, Fusion / Q000096:biosynthesis*; D012074:Remission Induction; D013997:Time Factors; D014212:Tretinoin / Q000008:administration & dosage*; D025721:WT1 Proteins / Q000096:biosynthesis*
chemical_list: D000970:Antineoplastic Agents; D015514:Oncogene Proteins, Fusion; D025721:WT1 Proteins; C093476:promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein; D014212:Tretinoin